Alnylam Pharmaceuticals, Inc. (ALNY)

Last Closing Price: 307.99 (2025-06-13)

Weighted-Average Shares Outstanding (Diluted) (Annual)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Alnylam Pharmaceuticals, Inc. (ALNY) had Weighted-Average Shares Outstanding (Diluted) of 127.65M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$2.25B
$-278.16M
$323.37M
$1.92B
$2.43B
$-176.88M
$-200.49M
$-377.38M
$-377.38M
$-278.16M
$-278.16M
$-278.16M
$-278.16M
$-176.88M
$-120.22M
127.65M
Weighted-Average Shares Outstanding (Diluted)
127.65M
$-2.18
$-2.18
Balance Sheet Financials
$3.30B
$502.78M
$944.70M
$4.24B
$1.19B
$1.02B
$2.99B
$4.17B
$67.09M
$67.09M
$67.09M
129.29M
Cash Flow Statement Financials
$-8.31M
$-116.84M
$294.16M
$814.88M
$968.65M
$153.77M
$272.08M
--
--
Fundamental Metrics & Ratios
2.78
--
--
0.94
15.27
85.62%
-7.87%
-7.87%
-5.35%
-16.79%
-12.37%
$-42.59M
--
--
--
0.53
4.12
5.55
65.80
-414.62%
-414.62%
-6.56%
-25.48%
$0.52
$-0.33
$-0.07